Page last updated: 2024-08-24

sparfloxacin and Bacterial Disease

sparfloxacin has been researched along with Bacterial Disease in 33 studies

Research

Studies (33)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (6.06)	18.7374
1990's	22 (66.67)	18.2507
2000's	6 (18.18)	29.6817
2010's	2 (6.06)	24.3611
2020's	1 (3.03)	2.80

Authors

Authors	Studies
Bridges, AJ; Culbertson, TP; Domagala, JM; Gambino, L; Hagen, SE; Karrick, G; Porter, K; Sanchez, JP; Sesnie, JA; Spense, FG	1
Anderson, BE; Burda, WN; Cormier, R; Edlinger, J; Harrington, L; Kapolka, R; Kodigepalli, KM; Roma, G; Shaw, LN; Thomas, J; Turos, E	1
Zhang, B	1
Betson, M; Bingham, M; Doyle, P; Hallworth, S; Harvey, R; Huxley, A; Kirk, R; Moat, J; Nelson, G; Pesnot, T; Tait, M	1
Cai, Y; Liang, D; Miao, J; Qiu, D; Wen, C; Xu, N	1
Murakawa, GJ; Sable, D	1
Aldridge, KE	1
Acar, J; Baquero, F; Bergan, T; Degener, J; Forsgren, A; Phillips, I; Schito, GC; Wiedemann, B	1
Akieda, Y; Itokawa, K; Kawaguchi, H; Kawamura, H; Nakayama, I; Suzuki, T; Watanabe, T; Yamaji, E	1
Denis, A; Moreau, NJ	1
Ahlén, S; Malmborg, AS	1
Ibuki, E; Masuda, N; Miyoshi, H; Nishino, T; Otsuki, M; Takahashi, Y	1
Goldstein, EJ	1
Choi, EC; Choi, KH; Hong, JS; Kim, SK; Lee, DK; Yoon, SJ	1
Choi, EC; Choi, KH; Kim, BK; Kim, JH; Kim, JW; Lee, JH	1
Dorr, MB; Lipsky, BA; Magner, DJ; Talbot, GH	1
Adelglass, J; Henry, DC; Jablonski, CK; Moller, DJ; Scheld, WM; Talbot, GH; Zhang, H	1
Finch, RG	1
Hooper, DC	2
Buffington, D; Garrison, N; Granito, K; Spector, S; Stafford, C; Talbot, GH; Zhang, H	1
Hu, D; Hu, P; Jiang, S; Jiang, Y; Li, S; Wang, Q; Zhu, L; Zou, Q	1
Padeĭskaia, EN	1
Hibi, H; Horiba, M; Naide, Y; Shinoda, M; Suzuki, K	1
Akaniro, JC; Arguedas, AG; Stutman, HR; Vargas, OM	1
Gutmann, L; Richard, P	1
Bouzard, D; Di Cesare, P; Fung-Tomc, J; Hoffmann, P; Kessler, R	1
Beumer, H; Hoepelman, IM; Rozenberg-Arska, M; Verhoef, J; Visser, MR	1
Allen, SD; Barry, AL; Fuchs, PC; Gerlach, EH; Pfaller, MA	1
Bodey, GP; Ho, DH; LeBlanc, B; Messer, M; Nguyen, H; Rolston, KV	1
Inoue, M; Kojima, T; Mitsuhashi, S	1
Kashimoto, S; Kojima, T; Kouno, K; Kurobe, N; Minami, A; Nakamura, S; Nakata, K; Ohue, T; Sakaguchi, Y; Yoshida, H	1

Reviews

8 review(s) available for sparfloxacin and Bacterial Disease

Article	Year
Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids. European journal of medicinal chemistry, 2019, Apr-15, Volume: 168 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles	2019
Quinolones in dermatology. Disease-a-month : DM, 2004, Volume: 50, Issue:7 Topics: Anti-Infective Agents; Area Under Curve; Bacterial Infections; Biological Availability; Ciprofloxacin; Fluoroquinolones; Humans; Intestinal Absorption; Microbial Sensitivity Tests; Nalidixic Acid; Quinolones; Skin Diseases; Structure-Activity Relationship	2004
[Significant role of newer quinolone antimicrobials in respiratory tract infection: focused on sparfloxacin]. The Japanese journal of antibiotics, 1994, Volume: 47, Issue:10 Topics: Anti-Infective Agents; Bacterial Infections; Fluoroquinolones; Humans; Photosensitivity Disorders; Quinolones; Respiratory Tract Infections	1994
Possible role for the new fluoroquinolones (levofloxacin, grepafloxacin, trovafloxacin, clinafloxacin, sparfloxacin, and DU-6859a) in the treatment of anaerobic infections: review of current information on efficacy and safety. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1996, Volume: 23 Suppl 1 Topics: Anti-Infective Agents; Bacteria, Anaerobic; Bacterial Infections; Fluoroquinolones; Humans; Levofloxacin; Naphthyridines; Ofloxacin; Piperazines; Quinolones; Safety; Syndrome	1996
A review of worldwide experience with sparfloxacin in the treatment of community-acquired pneumonia and acute bacterial exacerbations of chronic bronchitis. International journal of antimicrobial agents, 1999, Volume: 12, Issue:1 Topics: Acute Disease; Animals; Anti-Infective Agents; Bacterial Infections; Bronchitis; Chronic Disease; Clinical Trials as Topic; Community-Acquired Infections; Fluoroquinolones; Humans; Pneumonia, Bacterial	1999
New uses for new and old quinolones and the challenge of resistance. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000, Volume: 30, Issue:2 Topics: Anti-Infective Agents; Bacterial Infections; Drug Resistance, Microbial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Piperazines; Respiratory Tract Infections; Sensitivity and Specificity; Sexually Transmitted Diseases; Urinary Tract Infections	2000
The fluoroquinolones after ciprofloxacin and ofloxacin. Current clinical topics in infectious diseases, 2000, Volume: 20 Topics: Anti-Infective Agents; Bacterial Infections; Fluoroquinolones; Humans; Naphthyridines; Ofloxacin; Piperazines; Respiratory Tract Infections; Sexually Transmitted Diseases, Bacterial; Skin Diseases, Bacterial; Urinary Tract Infections	2000
Sparfloxacin and other new fluoroquinolones. The Journal of antimicrobial chemotherapy, 1992, Volume: 30, Issue:6 Topics: Animals; Anti-Infective Agents; Bacterial Infections; Enterobacteriaceae; Fluoroquinolones; Gram-Positive Bacteria; Humans; Mycoplasma; Quinolones	1992

Trials

5 trial(s) available for sparfloxacin and Bacterial Disease

Article	Year
[Multicenter evaluation on the efficacy and safety of sparfloxacin in the treatment of acute bacterial infections]. Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao, 2002, Volume: 33, Issue:2 Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Injections, Intravenous; Male; Middle Aged; Ofloxacin	2002
[The dose-response study of sparfloxacin against skin and soft tissue structure infections in the field of surgery]. The Japanese journal of antibiotics, 1993, Volume: 46, Issue:8 Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteria; Bacterial Infections; Connective Tissue Diseases; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Female; Fluoroquinolones; Humans; Male; Middle Aged; Quinolones; Skin Diseases, Infectious	1993
Comparison of sparfloxacin and clarithromycin in the treatment of acute bacterial maxillary sinusitis. Sparfloxacin Multicenter AMS Study Group. Clinical therapeutics, 1999, Volume: 21, Issue:2 Topics: Acute Disease; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Male; Maxillary Sinusitis	1999
Sparfloxacin for the treatment of acute bacterial maxillary sinusitis documented by sinus puncture. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2000, Volume: 84, Issue:1 Topics: Acute Disease; Anti-Infective Agents; Bacterial Infections; Fluoroquinolones; Follow-Up Studies; Humans; Maxillary Sinusitis; Punctures	2000
[A randomized controlled clinical study of sparfloxacin versus ofloxacin in the treatment of bacterial infections]. Zhonghua nei ke za zhi, 1999, Volume: 38, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Female; Fluoroquinolones; Humans; Male; Middle Aged; Ofloxacin	1999

Other Studies

20 other study(ies) available for sparfloxacin and Bacterial Disease

Article	Year
Synthesis and biological activity of 5-amino- and 5-hydroxyquinolones, and the overwhelming influence of the remote N1-substituent in determining the structure-activity relationship. Journal of medicinal chemistry, 1991, Volume: 34, Issue:3 Topics: Alkylation; Aminoquinolines; Animals; Anti-Bacterial Agents; Bacterial Infections; Chemical Phenomena; Chemistry; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Hydroxyquinolines; Mice; Microbial Sensitivity Tests; Molecular Structure; Piperazines; Pyrrolidines; Structure-Activity Relationship; Topoisomerase II Inhibitors	1991
Studies on the antimicrobial properties of N-acylated ciprofloxacins. Bioorganic & medicinal chemistry letters, 2012, Oct-15, Volume: 22, Issue:20 Topics: Acylation; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bartonella; Bartonella Infections; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections	2012
Novel C-7 carbon substituted fourth generation fluoroquinolones targeting N. Gonorrhoeae infections. Bioorganic & medicinal chemistry letters, 2020, 10-15, Volume: 30, Issue:20 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbon; Dose-Response Relationship, Drug; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Molecular Structure; Neisseria gonorrhoeae; Structure-Activity Relationship	2020
Increased activity of a new chlorofluoroquinolone, BAY y 3118, compared with activities of ciprofloxacin, sparfloxacin, and other antimicrobial agents against anaerobic bacteria. Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:7 Topics: Anti-Infective Agents; Bacteria, Anaerobic; Bacterial Infections; Ciprofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Quinolones	1994
European Study Group on Antibiotic Breakpoints. Breakpoint determination: sparfloxacin. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1994, Volume: 13, Issue:3 Topics: Bacterial Infections; Drug Resistance, Microbial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Quinolones	1994
Mechanisms of quinolone resistance in clinical isolates: accumulation of sparfloxacin and of fluoroquinolones of various hydrophobicity, and analysis of membrane composition. The Journal of antimicrobial chemotherapy, 1993, Volume: 32, Issue:3 Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Bacterial Outer Membrane Proteins; Cell Membrane; Chemical Phenomena; Chemistry, Physical; DNA Topoisomerases, Type II; DNA, Bacterial; DNA, Superhelical; Drug Resistance, Microbial; Enterobacteriaceae; Escherichia coli; Fluoroquinolones; Magnesium; Pseudomonas aeruginosa; Quinolones; Staphylococcus aureus	1993
In vitro activity of sparfloxacin compared with ciprofloxacin and ofloxacin against respiratory tract pathogens. Chemotherapy, 1993, Volume: 39, Issue:1 Topics: Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Respiratory Tract Infections	1993
In vitro and in vivo antibacterial activities of CS-940, a new 6-fluoro-8-difluoromethoxy quinolone. Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:5 Topics: Animals; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Drug Evaluation, Preclinical; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Mice; Naphthyridines; Piperazines; Pneumonia, Bacterial; Quinolones	1996
In-vitro and in-vivo activities of DW-116, a new fluoroquinolone. The Journal of antimicrobial chemotherapy, 1997, Volume: 39, Issue:4 Topics: Animals; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Dose-Response Relationship, Drug; Enterococcus faecalis; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Methicillin Resistance; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Ofloxacin; Piperazines; Pseudomonas aeruginosa; Quinolones; Staphylococcus aureus	1997
In-vitro and in-vivo antibacterial activity of CFC-222, a new fluoroquinolone. The Journal of antimicrobial chemotherapy, 1998, Volume: 41, Issue:2 Topics: Animals; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Fluoroquinolones; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Ofloxacin; Quinolones	1998
Safety profile of sparfloxacin, a new fluoroquinolone antibiotic. Clinical therapeutics, 1999, Volume: 21, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Bronchitis; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Data Interpretation, Statistical; Female; Fluoroquinolones; Heart Rate; Humans; Male; Middle Aged; Photosensitivity Disorders; Pneumonia, Bacterial; Quinolones; Sinusitis; Skin Diseases, Bacterial	1999
[Sparfloxacin (a long-acting difluoroquinolone)--an antibacterial preparation with the broad spectrum activity]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2002, Volume: 47, Issue:1 Topics: Anti-Infective Agents; Bacterial Infections; Clinical Trials as Topic; Delayed-Action Preparations; Fluoroquinolones; Humans; Tissue Distribution	2002
[Clinical and bacteriological study of sparfloxacin on bacterial prostatitis]. Hinyokika kiyo. Acta urologica Japonica, 1992, Volume: 38, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Bacteria; Bacterial Infections; Drug Evaluation; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prostatitis; Quinolones	1992
In vitro activity of sparfloxacin (AT-4140), a new quinolone agent, against invasive isolates from pediatric patients. Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:2 Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Mutation; Quinolones	1992
In vitro and in vivo evaluation of BMY 45243, a new 5-amino-naphthyridone derivative. Drugs under experimental and clinical research, 1992, Volume: 18, Issue:7 Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Mice; Microbial Sensitivity Tests; Naphthyridines; Quinolones; Solubility	1992
Comparative in vitro antibacterial activity of sparfloxacin (AT-4140; RP 64206), a new quinolone. Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:5 Topics: 4-Quinolones; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bacterial Infections; Culture Media; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Quality Control	1991
Multicenter evaluation of the in vitro activities of three new quinolones, sparfloxacin, CI-960, and PD 131,628, compared with the activity of ciprofloxacin against 5,252 clinical bacterial isolates. Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:4 Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines	1991
In vitro activity of sparfloxacin (CI-978; AT-4140) against clinical isolates from cancer patients. Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:11 Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Fleroxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Neoplasms	1990
In vitro activity of AT-4140 against clinical bacterial isolates. Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:11 Topics: 4-Quinolones; Anti-Infective Agents; Bacteria; Bacterial Infections; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Mutation; Topoisomerase II Inhibitors	1989
In vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinolone. Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:8 Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Enoxacin; Fluoroquinolones; Lung Diseases; Mice; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Skin Diseases, Infectious; Urinary Tract Infections	1989